# A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies

> **NCT00719862** · PHASE3 · COMPLETED · sponsor: **Meda Pharmaceuticals** · enrollment: 481 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Placebo nasal spray
- **DRUG:** 0.15% azelastine hydrochloride Nasal Spray

## Key facts

- **NCT ID:** NCT00719862
- **Lead sponsor:** Meda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 481 (ACTUAL)
- **Last updated:** 2010-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00719862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00719862, "A Study to Evaluate the Safety & Effectiveness of a Nasal Spray to Treat Seasonal Allergies". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00719862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*